79 related articles for article (PubMed ID: 17153514)
1. Hepatitis C knowledge among staff in U.S. drug treatment programs.
Strauss SM; Astone-Twerell JM; Munoz-Plaza C; Des Jarlais DC; Gwadz M; Hagan H; Osborne A; Rosenblum A
J Drug Educ; 2006; 36(2):141-58. PubMed ID: 17153514
[TBL] [Abstract][Full Text] [Related]
2. Correlates of drug treatment program staff's self efficacy to support their clients' hepatitis C virus (HCV) related needs.
Strauss SM; Astone-Twerell JM; Munoz-Plaza C; Des Jarlais DC; Gwadz M; Hagan H; Osborne A; Rosenblum A
Am J Drug Alcohol Abuse; 2007; 33(2):245-51. PubMed ID: 17497547
[TBL] [Abstract][Full Text] [Related]
3. Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services.
Strauss SM; Astone-Twerell J; Munoz-Plaza CE; Des Jarlais DC; Gwadz M; Hagan H; Osborne A; Rosenblum A
BMC Health Serv Res; 2007 Mar; 7():39. PubMed ID: 17346346
[TBL] [Abstract][Full Text] [Related]
4. Gaps in the drug-free and methadone treatment program response to Hepatitis C.
Strauss SM; Astone J; Vassilev ZP; Des Jarlais DC; Hagan H
J Subst Abuse Treat; 2003 Jun; 24(4):291-7. PubMed ID: 12867202
[TBL] [Abstract][Full Text] [Related]
5. Provision of hepatitis C education in a nationwide sample of drug treatment programs.
Astone J; Strauss SM; Vassilev ZP; Des Jarlais DC
J Drug Educ; 2003; 33(1):107-17. PubMed ID: 12773028
[TBL] [Abstract][Full Text] [Related]
6. Integrating hepatitis C services into existing HIV services: the experiences of a sample of U.S. drug treatment units.
Strauss SM; Astone JM; Des Jarlais DC; Hagan H
AIDS Patient Care STDS; 2005 Feb; 19(2):78-88. PubMed ID: 15716639
[TBL] [Abstract][Full Text] [Related]
7. Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment.
Talal AH; Dimova RB; Seewald R; Peterson RH; Zeremski M; Perlman DC; Des Jarlais DC
J Subst Abuse Treat; 2013 Jan; 44(1):115-9. PubMed ID: 22405884
[TBL] [Abstract][Full Text] [Related]
8. Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S.
Strauss SM; Rindskopf DM; Astone-Twerell JM; Des Jarlais DC; Hagan H
Drug Alcohol Depend; 2006 Jun; 83(1):15-24. PubMed ID: 16289523
[TBL] [Abstract][Full Text] [Related]
9. A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States.
Strauss SM; Astone JM; Jarlais DD; Hagan H
Drug Alcohol Depend; 2004 Mar; 73(3):227-36. PubMed ID: 15036545
[TBL] [Abstract][Full Text] [Related]
10. Knowledge of and interest in hepatitis C treatment at a methadone clinic.
Walley AY; White MC; Kushel MB; Song YS; Tulsky JP
J Subst Abuse Treat; 2005 Mar; 28(2):181-7. PubMed ID: 15780548
[TBL] [Abstract][Full Text] [Related]
11. Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.
Treloar C; Hull P; Dore GJ; Grebely J
Drug Alcohol Rev; 2012 Nov; 31(7):918-24. PubMed ID: 22612899
[TBL] [Abstract][Full Text] [Related]
12. Desired social distance from people who have hepatitis C virus: an exploration among staff in health care, dentistry, drug treatment, and tattoo/body piercing.
Suarez AE; Redmond D
Subst Use Misuse; 2014 Mar; 49(4):466-74. PubMed ID: 24224774
[TBL] [Abstract][Full Text] [Related]
13. Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs.
Munoz-Plaza CE; Strauss SM; Astone-Twerwll JM; Des Jarlais DC; Hagan H
J Psychoactive Drugs; 2006 Sep; 38(3):233-41. PubMed ID: 17165366
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and knowledge of hepatitis C in a middle-aged population, Dunedin, New Zealand.
Vermunt J; Fraser M; Herbison P; Wiles A; Schlup M; Schultz M
World J Gastroenterol; 2015 Sep; 21(35):10224-33. PubMed ID: 26401088
[TBL] [Abstract][Full Text] [Related]
15. Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia.
Treloar C; Rance J; Grebely J; Dore GJ
Drug Alcohol Depend; 2013 Dec; 133(2):529-34. PubMed ID: 23932843
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area.
Bräu N; Bini EJ; Shahidi A; Aytaman A; Xiao P; Stancic S; Eng R; Brown ST; Paronetto F
Am J Gastroenterol; 2002 Aug; 97(8):2071-8. PubMed ID: 12190179
[TBL] [Abstract][Full Text] [Related]
17. Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for hepatitis C virus infection.
Canfield KM; Smyth E; Batki SL
Subst Use Misuse; 2010 Mar; 45(4):496-514. PubMed ID: 20141461
[TBL] [Abstract][Full Text] [Related]
18. Knowledge about Hepatitis-C among methadone maintenance treatment patients in Israel.
Cohen-Moreno R; Schiff M; Levitt S; Bar-Hamburger R; Strauss S; Neumark Y
Subst Use Misuse; 2010; 45(1-2):58-76. PubMed ID: 20025439
[TBL] [Abstract][Full Text] [Related]
19. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
[TBL] [Abstract][Full Text] [Related]
20. Awareness of hepatitis C virus transmission routes among patients, their household contacts and health care staff: does perception match the reality?
Tiftikçi A; Atuğ O; Tözün N
Turk J Gastroenterol; 2009 Jun; 20(2):104-7. PubMed ID: 19530042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
